Stocksigma LogoStocksigma Logo

Dipna Pharmachem Reports Q1 FY27 Standalone Financial Results

Dipna Pharmachem reported standalone total income of Rs 2,379.06 lakhs for the quarter ended 30th Jun'26, rising 28.60% YoY from Rs 1,850.04 lakhs in 30th

Dipna Pharmachem Reports Q1 FY27 Standalone Financial Results

Dipna Pharmachem Ltd 路 Others (Uncategorized) 路 04 Nov 2026, 11:21 pm

Dipna Pharmachem Reports Q1 FY27 Standalone Financial Results Dipna Pharmachem reported standalone total income of Rs 2,379.06 lakhs for the quarter ended 30th Jun'26, rising 28.60% YoY from Rs 1,850.04 lakhs in 30th Jun'25 and up sharply QoQ from Rs 205.03 lakhs. Net profit declined 30.87% YoY to Rs 39.42 lakhs compared to Rs 57.02 lakhs in 30th Jun'25, but grew 120.72% QoQ from Rs 17.86 lakhs. Basic and diluted EPS stood at Rs 0.15 versus Rs 0.24 YoY. Total expenses reached Rs 2,326.64 lakhs, primarily driven by purchase of stock-in-trade at Rs 1,890.28 lakhs.

Original exchange filing (PDF)

More announcements from Dipna Pharmachem Ltd

All Dipna Pharmachem Ltd announcements